Nr 661 Acute Sinusitis Pharmacologic Management

Reserve antibiotics for:
  • Persistent and not improving symptoms > 10 days
  • Severe symptoms for > 3-4 days

Quinolones

Mechanism of Action: Quinolones inhibit the action of DNA gyrase, an enzyme essential for bacterial replication.

Levofloxacin (Levaquin®)

  • Dosage:
    • Adults (>18 years):
      • Usual: 500 mg once daily for 10-14 days
      • Alternative: 750 mg daily for 5 days
    • Children: Not recommended
  • How supplied:
    • Tabs: 250 mg, 500 mg, 750 mg
    • Oral solution: 480 mL
  • Comments:
    • Reduce dose for impaired renal function.
    • Avoid drugs that prolong the QT interval.
    • Absorption significantly decreased by dairy products, multivitamins, and calcium-containing products.
    • Possible increased risk of tendinitis or tendon rupture.
    • Causes photosensitivity; monitor for this side effect.
    • Not recommended for children under 18 years or pregnant women due to potential impairment in bone and cartilage formation.
    • Monitor for hypoglycemic reactions in patients with diabetes.

Moxifloxacin (Avelox®)

  • Dosage:
    • Adults: 1 tablet once daily for 5-7 days
    • Children: Not indicated
  • How supplied:
    • Tabs: 400 mg
  • Comments:
    • Similar considerations as levofloxacin, particularly regarding QT prolongation and photosensitivity.
    • Avoid in pregnancy and lactation unless absolutely necessary.

PREGNANCY/LACTATION CONSIDERATIONS

  • Sinusitis in Pregnancy: May be aggravated by physiologic nasal congestion due to pregnancy.
  • Decongestant Use: Mild decongestants are considered safe for short-term use, but their effectiveness is not proven.
  • Antibiotic Use: Avoid unless absolutely necessary. Tetracyclines and quinolones should be avoided during pregnancy or lactation due to potential risks.

CONSULTATION/REFERRAL

  • Consider consultation or referral to a specialist if symptoms persist despite treatment, or if there are concerns regarding the management of sinusitis in pregnancy or other special populations.